Novel use of anifrolumab in a young patient with Jo-1-positive juvenile dermatomyositis


Windschall D., Hinze T., Hardt S., Aydın D., Gohar F.

Rheumatology Advances in Practice, cilt.1, ss.1, 2026 (Hakemli Dergi)